| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | Chief People Officer | Stock option (right to buy) | 230,000 | $1,313,300 | $5.71 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | 30 Jan 2026 | 1 | +$1,313,300 | 4 | Chief People Officer | 02 Feb 2026, 16:04 |
| FHTX | Foghorn Therapeutics Inc. | 22 Jan 2025 | 1 | +$502,550 | 4 | Chief People Officer | 24 Jan 2025, 16:13 |
| FHTX | Foghorn Therapeutics Inc. | 20 Sep 2024 | 6 | -$231,506 | 4 | Chief People Officer | 24 Sep 2024, 16:01 |
| FHTX | Foghorn Therapeutics Inc. | 18 Sep 2024 | 3 | -$73,263 | 4 | Chief People Officer | 20 Sep 2024, 16:00 |
| FHTX | Foghorn Therapeutics Inc. | 16 Sep 2024 | 6 | -$67,431 | 4 | Chief People Officer | 18 Sep 2024, 16:01 |
| FHTX | Foghorn Therapeutics Inc. | 24 Jan 2024 | 1 | +$275,400 | 4 | Chief People Officer | 25 Jan 2024, 16:03 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jan 2023 | 1 | $0 | 4 | Chief People Officer | 30 Jan 2023, 16:03 |
| FHTX | Foghorn Therapeutics Inc. | 01 Aug 2022 | 0 | $0 | 3/A | Chief People Officer | 09 Sep 2022, 19:38 |
| FHTX | Foghorn Therapeutics Inc. | 01 Aug 2022 | 1 | $0 | 4 | Chief People Officer | 03 Aug 2022, 21:06 |